Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Study to Evaluate and Explore Scales for Repetitive and Restricted Behaviors and Digital Biomarkers in Children, Adolescents, and Adults With Autism Spectrum Disorder (ASD)

NCT03611075 is registered in ClinicalTrials.gov with Hoffmann-La Roche as lead sponsor.

NCT NCT03611075
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03611075 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Study to Evaluate and Explore Scales for Repetitive and Restricted Behaviors and Digital Biomarkers in Children, Adolescents, and Adults With Autism Spectrum Disorder (ASD)
Lead sponsor
Hoffmann-La Roche
Phase
Phase 1
Overall status
Completed
Start date
August 13, 2018
Completion date
May 21, 2020
Enrollment
144 (actual)
Sites
18

Conditions

As the registry lists them; a condition with its own page is linked.

autism spectrum disorder